B Lineage Lymphoblastic Lymphoma
2 clinical trials · Condition
◉ Watch B Lineage Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Co-administration of CART22-65s and huCART19 for B-ALL (NCT05674175) | Stephan Grupp MD PhD | 2023-01-25 |
| Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy) (NCT05480449) | Stephan Grupp MD PhD | 2022-09-20 |
Track B Lineage Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.